Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update Mid-year 3 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year-2 CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Research Update from Dr. McCleary-Wheeler targeting epigenetics in Lymphoma.
Research Update End-Year 2 CHF-02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B-Cell Lymphoma
Research Update from Dr. Breen regarding aiding prognosis of Canine Diffuse Large B-Cell Lymphoma.
Research Update End-Year 2 CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Research Update from Dr. Trepanier on genetic and environmental risks of lymphoma in Boxer dogs.
Research Update End-Year-1 CHF-02502: Precision Medicine for Canine Lymphoma
Research update from Dr. Nicola Mason to profile lymphoma and enable targeted therapy.
Continue reading “Research Update End-Year-1 CHF-02502: Precision Medicine for Canine Lymphoma”
Research Update End-Year 1 CHF-02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs
Update from Dr. Lauren Trepanier’s research looking at any genetic and environmental risk for lymphoma in dogs.
Research Update End-Year-1 CHF 02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma
Research update and the end of the first year from Dr. Matthew Breen looking at prediction of prognosis and outcome for various forms of lymphoma.
Research Update End-Year 3 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
End-year 3 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.
One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma
Update from the first year of work on MAF co-sponsored project D16CA-056, Measuring chemotherapy drug resistance in dogs with T-cell lymphoma; Paul R. Hess, DVM, PhD, North Carolina State University.
Continue reading “One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma”
